JPRN-UMIN000001258已完成3 期
Therapeutic fficacy of ezetimibe in patients with nonalcoholic steatohepatitis (NASH): a pilot study. - Efficacy of ezetimibe in NASH patients
Division of Gastroenterology, Yokohama City University Hospital0 个研究点目标入组 10 人开始时间: 2008年7月23日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •a.The criteria for exclusion from participation in the study: history of hepatic disease, such as chronic hepatitis C or concurrent active hepatitis B (serum positive for hepatitis B surface antigen), autoimmune hepatitis, primary biliary cirrhosis (PBC), sclerosing cholangitis, hemochromatosis, alpha1-antitrypsin deficiency, Wilsons disease, and current or past consumption of more than 20 g of alcohol daily. b. None of the patients had any clinical evidence of hepatic decompensation, such as hepatic encephalopathy, ascites, variceal bleeding, or elevated serum bilirubin level to more than twofold the upper limit of normal.
研究者
相似试验
已完成
不适用
A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease-Its effect on biliary bigly metabolismhypercholesterolemiaJPRN-UMIN000004183Hiroshima University hospital Department of General Medicine60
已完成
不适用
Efficacy of Ezetimibe for the patients with Non-alcoholic fatty liver disease (NAFLD)JPRN-UMIN000001071Osaka City University Graduate School of Medicine60
招募中
不适用
Effects of ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease; randomized comparison of LDL-cholesterol targeting <70 versus <55mg/dL; Ez-PAVE trialDiseases of the circulatory systemKCT0005547Yonsei University Health System, Severance Hospital3,048
已完成
不适用
Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.Dyslipidemia complicated insulin resistanceJPRN-UMIN000005775The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital47
进行中（未招募）
不适用
Efficacy, safety, and tolerability of ezetimibe in coadministration with simvastin in the therapy of adolescent with heterozygous familial hypercholesterolemiaTherapy of adolescents with etherozygous familial hypercholesterolemiaMedDRA version: 6.1Level: PTClassification code 10020603EUCTR2004-002627-40-ITSCHERING-PLOUGH